MARCOS
GONZÁLEZ DÍAZ
Investigador en el periodo 1993-2023
Universidade de São Paulo
São Paulo, BrasilPublicaciones en colaboración con investigadores/as de Universidade de São Paulo (1)
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477